Tempest Therapeutics's total assets for Q2 2025 were $24.48M, a decrease of -23.88% from the previous quarter. TPST total liabilities were $14.70M for the fiscal quarter, a -30.10% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.